Abstract:Atherosclerosis is one kind of chronic inflammatory disease, in which multiple types of immune cells or factors are involved. Data from experimental and clinical studies on atherosclerosis have confirmed the key roles of immune cells and inflammation in such process. The thymus as a key organ in T lymphocyte ontogenesis has an important role in optimizing immune system function throughout the life, and dysfunction of thymus has been proved to be associated with severity of atherosclerosis. Based on previous research, we begin with the hypothesis that low density lipoprotein or cholesterol reduces the expression of the thymus transcription factor Foxn1 via low density lipoprotein receptors on the membrane surface and low density lipoprotein receptor related proteins on the cell surface, which cause the thymus function decline or degradation. The imbalance of T cell subgroups and the decrease of naive T cells due to thymus dysfunction cause the increase or decrease in the secretion of various inflammatory factors, which in turn aggravates or inhibits atherosclerosis progression and cardiovascular events. Hence, thymus may be the pivotal role in coronary heart disease mediated by atherosclerosis and cardiovascular events and it can imply a novel treatment strategy for the clinical management of patients with atherosclerosis in addition to different commercial drugs. Modulation of immune system by inducing thymus function may be a therapeutic approach for the prevention of atherosclerosis. Purpose of this review is to summarize and discuss the recent advances about the impact of thymus function on atherosclerosis by the data from animal or human studies and the potential mechanisms.

Research Progress on the Relationship Between T-Lymphocytes and Atherosclerosis

Progress in the Research of Relationship Between Regulatory T Cells and Atherosclerosis

A bibliometric analysis of T cell and atherosclerosis

Role of Toll-like Receptor9 in Progression of Atherosclerosis:Recent Advances

Th17/Treg Imbalance and Atherosclerosis

Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.

Research Progress on the Active Ingredients of Traditional Chinese Medicine in the Intervention of Atherosclerosis: A Promising Natural Immunotherapeutic Adjuvant

Relationship Between Th17 Cells and Atherosclerosis

Research Progress in Relationship between Leukotrienes and Arteriosclerosis

The Emerging Role of Th1 Cells in Atherosclerosis and Its Implications for Therapy

Knowledge mapping of B cell and atherosclerosis over the past 20 years: A bibliometric analysis

Research Progress of Pathogenesis of Atherosclerosis

Lymphatic Vessels: A Potential Approach to the Treatment of Atherosclerosis?

Progress on the Role of Macrophages in Atherosclerosis

Therapeutic Targeting of Pattern Recognition Receptors to Modulate Inflammation in Atherosclerosis

[Chronic Inflammation, Autoimmunity and Atherosclerosis].

Pharmacological therapy targeting the immune response in atherosclerosis

The Pivotal Role Of Thymus In Atherosclerosis Mediated By Immune And Inflammatory Response

T-Cell Metabolic Reprogramming in Atherosclerosis

Regulatory T Cells As a New Therapeutic Target for Atherosclerosis

Expression and Clinical Significance of CD4+CD28-T Cell on Acute Coronary Syndromes